CDEK
← All organizations

AYTU BioScience

For profitContributed to NMEWebsite ↗

Also known as: AYTU | AYTU BIOPHARMA | Aytu BioPharma, Inc. | Aytu BioScience, Inc.

Phase 1Phase 2Phase 3Phase 4

First clinical trial

Jan 31, 2024

First marketed drug

Jun 1, 2002

Last known activity

Jan 31, 2024

Acquired by Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc → AYTU BioScience → Neos Therapeutics, Inc on Feb 10, 2021

Timeline

1960s

  1. Dec 10, 1966

    Neos Therapeutics, Inc— Acquired

1990s

  1. Oct 28, 1996

    capromab pendetide— NDA Organization

2000s

  1. Jun 1, 2002

    AYTU BioScience— Founded

  2. Dec 19, 2008

    zolpidem— NDA Secondary Org

2010s

  1. Jun 29, 2012

    hydrocodone— Marketing Organization

2020s

  1. Feb 10, 2021

    Neos Therapeutics, Inc— Acquired By

  2. Feb 10, 2021

    Neos Therapeutics, Inc— Now

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (0 own, 2 via acquisition)

Marketed drugs (10)

Subsidiaries (1 direct, 25 total across the full acquisition tree)

Recent trials (1)

Details

Founded
Englewood, CO, US Jun 1, 2002
Last known activity
Jan 31, 2024